Novartis drug Signifor® recommended by FDA advisory committee for approval to treat patients with Cushing’s disease
7 November 2012 | By Novartis
Committee votes unanimously in favor of Signifor (pasireotide)...
List view / Grid view
7 November 2012 | By Novartis
Committee votes unanimously in favor of Signifor (pasireotide)...
6 November 2012 | By Pfizer
The U.S. FDA has approved XELJANZ®...
25 October 2012 | By Novo Nordisk
“This meeting will focus on the cardiovascular safety of two products..."
18 October 2012 | By Biogen Idec
Biogen Idec announced that the U.S. FDA has extended the initial PDUFA date for its review...
17 October 2012 | By Biogen Idec
Biogen Idec announced that the U.S. FDA has extended the initial PDUFA date...
16 October 2012 | By Roche
Hospital point-of-care system for blood glucose testing with improved accuracy and wireless data transfer Next-generation system...
20 September 2012 | By Amgen
A new indication for Prolia® approved...
12 September 2012 | By Gerresheimer AG
Gerresheimer Medical Plastic Systems Dongguan Co. is an FDA-inspected medical device...
12 September 2012 | By Sanofi
AUBAGIO® (teriflunomide), a once-daily, oral treatment for relapsing Multiple Sclerosis...
4 September 2012 | By Pfizer
“BOSULIF is the third new medicine to be approved by the FDA in just 13 months..."
27 August 2012 | By Gilead Sciences
Gilead Sciences, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved StribildTM...
21 August 2012 | By Pfizer
The U.S. FDA has extended the action date by three months for the NDA for tofacitinib...
13 August 2012 | By Sanofi
Breakthrough device design talks patients and caregivers through the injection process...
13 August 2012 | By Roche
First major treatment advance in more than 25 years for sight-threatening condition...
7 August 2012 | By Abbott
The U.S. FDA has approved the Omnilink Elite® Vascular Balloon-Expandable Stent System...